Medical Properties Trust (NYSE:MPW - Get Free Report)'s stock had its "sell (d-)" rating restated by analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.
A number of other analysts also recently issued reports on MPW. Zacks Research upgraded shares of Medical Properties Trust from a "strong sell" rating to a "hold" rating in a report on Wednesday, August 20th. Royal Bank Of Canada decreased their price objective on shares of Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating for the company in a report on Monday, June 30th. Wells Fargo & Company decreased their price objective on shares of Medical Properties Trust from $5.00 to $4.50 and set an "underweight" rating for the company in a report on Wednesday, August 27th. Finally, Wall Street Zen downgraded shares of Medical Properties Trust from a "hold" rating to a "sell" rating in a report on Saturday, July 5th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Reduce" and an average target price of $5.40.
View Our Latest Stock Analysis on Medical Properties Trust
Medical Properties Trust Stock Performance
Shares of MPW stock opened at $5.39 on Wednesday. The firm has a 50-day moving average of $4.61 and a 200-day moving average of $4.77. The company has a market cap of $3.24 billion, a P/E ratio of -2.26 and a beta of 1.39. The company has a debt-to-equity ratio of 2.00, a current ratio of 2.76 and a quick ratio of 2.76. Medical Properties Trust has a one year low of $3.51 and a one year high of $6.34.
Medical Properties Trust (NYSE:MPW - Get Free Report) last announced its earnings results on Thursday, July 31st. The real estate investment trust reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). The firm had revenue of $240.36 million during the quarter, compared to analysts' expectations of $231.90 million. Medical Properties Trust had a negative net margin of 155.20% and a negative return on equity of 28.80%. The business's revenue for the quarter was down 9.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.23 EPS. Equities research analysts forecast that Medical Properties Trust will post 0.78 EPS for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the company. Itau Unibanco Holding S.A. purchased a new position in shares of Medical Properties Trust in the first quarter worth $41,000. Brighton Jones LLC purchased a new position in shares of Medical Properties Trust in the second quarter worth $44,000. Focus Partners Advisor Solutions LLC purchased a new position in shares of Medical Properties Trust in the second quarter worth $44,000. Drive Wealth Management LLC purchased a new position in shares of Medical Properties Trust in the second quarter worth $45,000. Finally, Norges Bank purchased a new position in shares of Medical Properties Trust in the second quarter worth $45,000. 71.79% of the stock is owned by hedge funds and other institutional investors.
About Medical Properties Trust
(
Get Free Report)
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.